The MiMedx investigations focus on former CEO behavior

“PETE LIED!” SAYS MIMEDX’S BOARD OF DIRECTORS (Orthopedics This Week)

Parker "Pete" Petit

After the stock market closed Thursday, May 23, the MiMedx board of directors set fire to ousted CEO Parker (Pete) Petit’s blueprint for retaking control of the company, accusing him and his management team of a variety of legally dubious accounting and employee management behaviors. Buried deep in the report is a poison pill targeting Petit personally (see below). Less than two hours later, the Wall Street Journal reported that an internal investigation found that MiMedx’s products were never...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top